Physiological signaling functions of reactive oxygen species in stem cells: from flies to man

SA Sinenko, TY Starkova, AA Kuzmin… - Frontiers in cell and …, 2021 - frontiersin.org
Reactive oxygen species (ROS), superoxide anion and hydrogen peroxide, are generated
as byproducts of oxidative phosphorylation in the mitochondria or via cell signaling-induced …

Stem cells and the impact of ROS signaling

CL Bigarella, R Liang, S Ghaffari - Development, 2014 - journals.biologists.com
An appropriate balance between self-renewal and differentiation is crucial for stem cell
function during both early development and tissue homeostasis throughout life. Recent …

Genetic basis and molecular profiling in myeloproliferative neoplasms

D Luque Paz, R Kralovics, RC Skoda - Blood, 2023 - ashpublications.org
Abstract BCR:: ABL1-negative myeloproliferative neoplasms (MPNs) are clonal diseases
originating from a single hematopoietic stem cell that cause excessive production of mature …

A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

F Passamonti, T Giorgino, B Mora, P Guglielmelli… - Leukemia, 2017 - nature.com
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative
neoplasms with variable risk of evolution into post-PV and post-ET myelofibrosis, from now …

Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms

P Lundberg, A Karow, R Nienhold… - Blood, The Journal …, 2014 - ashpublications.org
Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by
aberrant hematopoietic proliferation and an increased tendency toward leukemic …

The role of reactive oxygen species in acute myeloid leukaemia

JR Sillar, ZP Germon, GN De Iuliis, MD Dun - International journal of …, 2019 - mdpi.com
Acute myeloid leukaemia (AML) is an aggressive haematological malignancy with a poor
overall survival. Reactive oxygen species (ROS) have been shown to be elevated in a wide …

JAK2 V617F allele burden in polycythemia vera: burden of proof

AR Moliterno, H Kaizer, BN Reeves - Blood, 2023 - ashpublications.org
Polycythemia vera (PV) is a hematopoietic stem cell neoplasm defined by activating somatic
mutations in the JAK2 gene and characterized clinically by overproduction of red blood cells …

Inflammation and myeloproliferative neoplasms

F Lussana, A Rambaldi - Journal of autoimmunity, 2017 - Elsevier
Myeloproliferative neoplasms (MPN) include three main entities: Polycythemia Vera (PV),
Essential Thrombocythemia (ET), and Myelofibrosis (MF). MPN represent a unique model of …

Clinical and molecular response to interferon-α therapy in essential thrombocythemia patients with CALR mutations

E Verger, B Cassinat, A Chauveau… - Blood, The Journal …, 2015 - ashpublications.org
Myeloproliferative neoplasms are clonal disorders characterized by the presence of several
gene mutations associated with particular hematologic parameters, clinical evolution, and …

Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side

R Prieto-Bermejo, M Romo-González… - Journal of Experimental …, 2018 - Springer
Oxidative stress is related to ageing and degenerative diseases, including cancer. However,
a moderate amount of reactive oxygen species (ROS) is required for the regulation of …